FDA Inspection 1299008 — AbbVie Inc.

AbbVie Inc. — FEI 3009751352

The FDA completed an inspection of AbbVie Inc. on Apr 27, 2026 in North Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 27, 2026
Fiscal Year
2026
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
North Chicago, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.